Ozempic and Wegovy linked to rare risk of sudden vision loss
Wednesday, October 14, 2026Want headlines delivered to your inbox?
Subscribe to our free daily newsletter.
Popular diabetes and weight loss drugs such as Ozempic and Wegovy have been linked to a slightly increased risk of a rare condition that can cause sudden, potentially permanent vision loss. Although the risk remains very low, Rutgers researchers say the findings warrant attention as millions of people turn to GLP-1 medications. (via Science Daily)
Read the Full StoryThis article will expire in 24 days.
In the News...
View All Recent News
- Scientists find a youth protein that helps aging brain cells act young again
- Scientists tested 39 sweeteners and uncovered surprising gut effects
- Scientists discover that male and female skin play by different rules
- Scientists uncover 3 key brain pathways linked to lasting depression relief
- Eating blueberries every day may have a surprising effect on your mood
- Scientists link a strange sugar in red meat to a 63% higher diabetes risk
- Scientists discover a natural compound that could protect the brain from too much salt
- Magic mushroom ingredient takes the fight out of aggressive fish
- Brain cells meant to protect us may be fueling cognitive decline
- Stanford’s new microscope reveals living cells like never before
- New drug reverses severe fatty liver disease by repairing the gut
- Scientists discover how deep sleep builds muscle, burns fat, and boosts the brain
- Yale scientists discover how stress changes the brain to make memories stronger
- Scientists discover how exercise reverses muscle aging
- USC scientists discover how to create a never-ending supply of cancer-fighting cells
- A protein that fuels cancer could also be the key to fighting it
- Rare study reveals a striking divide inside an Alzheimer’s patient’s brain
- Scientists discover a surprising danger in smaller cancer cells
- Strokes have nearly doubled among younger adults, and scientists aren't sure why
- Eating late at night linked to up to 30% higher risk of liver disease